V. Carreño

887 total citations
32 papers, 710 citations indexed

About

V. Carreño is a scholar working on Hepatology, Epidemiology and Rheumatology. According to data from OpenAlex, V. Carreño has authored 32 papers receiving a total of 710 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Hepatology, 22 papers in Epidemiology and 8 papers in Rheumatology. Recurrent topics in V. Carreño's work include Hepatitis C virus research (28 papers), Hepatitis B Virus Studies (20 papers) and Liver Disease Diagnosis and Treatment (16 papers). V. Carreño is often cited by papers focused on Hepatitis C virus research (28 papers), Hepatitis B Virus Studies (20 papers) and Liver Disease Diagnosis and Treatment (16 papers). V. Carreño collaborates with scholars based in Spain, Switzerland and France. V. Carreño's co-authors include Inmaculada Castillo, Juan Antonio Quiroga, Javier Bartolomé, Julio Martín‐García, Sonia Navas, Carlos Caramelo, Patricia de Sequera, Alberto Ortíz, Marián Goicoechea and Antonio Madejón and has published in prestigious journals such as Hepatology, Kidney International and The Journal of Infectious Diseases.

In The Last Decade

V. Carreño

32 papers receiving 674 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
V. Carreño Spain 14 514 468 98 81 69 32 710
C Naret France 11 148 0.3× 165 0.4× 102 1.0× 19 0.2× 137 2.0× 19 386
A.L.W.F. Eddleston United Kingdom 15 611 1.2× 680 1.5× 29 0.3× 83 1.0× 8 0.1× 23 946
C Martín-Vega Spain 7 508 1.0× 493 1.1× 104 1.1× 37 0.5× 6 0.1× 13 650
Ulrike Mihm Germany 15 680 1.3× 635 1.4× 30 0.3× 137 1.7× 6 0.1× 42 850
V. Carreño Spain 19 880 1.7× 864 1.8× 35 0.4× 98 1.2× 5 0.1× 66 1.1k
Terryl J. Ortego United States 5 1.2k 2.4× 1.1k 2.3× 43 0.4× 71 0.9× 12 0.2× 5 1.5k
Nai‐Jen Hou Taiwan 16 943 1.8× 917 2.0× 20 0.2× 65 0.8× 9 0.1× 38 1.1k
A. Bionda Italy 11 138 0.3× 191 0.4× 27 0.3× 25 0.3× 24 0.3× 19 521
M Duffaut France 16 971 1.9× 827 1.8× 15 0.2× 108 1.3× 12 0.2× 49 1.2k
Blaine Hollinger United States 12 487 0.9× 506 1.1× 23 0.2× 56 0.7× 6 0.1× 17 626

Countries citing papers authored by V. Carreño

Since Specialization
Citations

This map shows the geographic impact of V. Carreño's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by V. Carreño with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites V. Carreño more than expected).

Fields of papers citing papers by V. Carreño

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by V. Carreño. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by V. Carreño. The network helps show where V. Carreño may publish in the future.

Co-authorship network of co-authors of V. Carreño

This figure shows the co-authorship network connecting the top 25 collaborators of V. Carreño. A scholar is included among the top collaborators of V. Carreño based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with V. Carreño. V. Carreño is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lucas, Susana de, Javier Bartolomé, Elena Rodríguez‐Iñigo, et al.. (2001). Distribution of hepatitis C virus infection in liver biopsies from children and adults with chronic hepatitis C. Journal of Medical Virology. 64(1). 1–5. 11 indexed citations
2.
Carreño, V., et al.. (2001). Interleukin-12 in the treatment of chronic hepatitis B and C. Antiviral Research. 52(2). 181–188. 32 indexed citations
3.
Carreño, V., M Rico, Margarita Pardo, & Juan Antonio Quiroga. (2001). Extended follow-up of anti-HBe-positive patients with chronic hepatitis B retreated with ribavirin and interferon-α. Antiviral Research. 52(2). 147–152. 4 indexed citations
4.
Martín‐García, Julio, Patricia de Sequera, Juan Antonio Quiroga, et al.. (2000). ROLE OF HAEMODIALYSIS AND HEPATITIS C VIRUS INFECTION IN SPONTANEOUS AND INDUCED CYTOKINE PRODUCTION OF PATIENTS WITH CHRONIC RENAL DISEASE. Cytokine. 12(8). 1248–1252. 11 indexed citations
5.
Carreño, V., Patrick Marcellin, S. Hadziyannis, et al.. (1999). Retreatment of chronic hepatitis B e antigen-positive patients with recombinant interferon alfa-2a. Hepatology. 30(1). 277–282. 53 indexed citations
6.
Martín‐García, Julio, Sonia Navas, M. Teresa Fernández‐Sánchez, et al.. (1999). In vitro effect of amantadine and interferon α-2a on hepatitis C virus markers in cultured peripheral blood mononuclear cells from hepatitis C virus-infected patients. Antiviral Research. 42(1). 59–70. 34 indexed citations
7.
Goicoechea, Marián, Julio Martín‐García, Patricia de Sequera, et al.. (1998). Role of cytokines in the response to erythropoietin in hemodialysis patients. Kidney International. 54(4). 1337–1343. 119 indexed citations
8.
Quiroga, Juan Antonio, Julio Martín‐García, Sonia Navas, & V. Carreño. (1998). Induction of Interleukin‐12 Production in Chronic Hepatitis C Virus Infection Correlates with the Hepatocellular Damage. The Journal of Infectious Diseases. 178(1). 247–251. 45 indexed citations
9.
Pardo, Margarita, Inmaculada Castillo, H Oliva, et al.. (1997). A pilot study of recombinant interleukin-2 for treatment of chronic hepatitis C. Hepatology. 26(5). 1318–1321. 23 indexed citations
10.
Tomás, JF, Elena Rodríguez‐Iñigo, Javier Bartolomé, et al.. (1997). Detection of hepatitis G virus from serum and liver of a patient with long-term liver dysfunction after autologous bone marrow transplantation. Bone Marrow Transplantation. 19(10). 1053–1057. 3 indexed citations
11.
12.
Quiroga, Jorge, Margarita Pardo, Sonia Navas, Julio Martín‐García, & V. Carreño. (1996). Patterns of Immune Responses to the Host-Encoded GOR and Hepatitis C Virus Core-Derived Epitopes with Relation to Hepatitis C Viremia, Genotypes, and Liver Disease Severity. The Journal of Infectious Diseases. 173(2). 300–305. 8 indexed citations
13.
Pernas, María, Javier Bartolomé, Inmaculada Castillo, et al.. (1995). Sequence of non-structural regions 3 and 5 of hepatitis C virus genomes from Spanish patients: existence of a predominant variant related to type 1b. Journal of General Virology. 76(2). 415–420. 4 indexed citations
14.
Pardo, Margarita, Inmaculada Castillo, Sonia Navas, & V. Carreño. (1995). Treatment of chronic hepatitis C with cirrhosis with recombinant human granulocyte colony‐stimulating factor plus recombinant interferon‐alpha. Journal of Medical Virology. 45(4). 439–444. 16 indexed citations
15.
López‐Alcorocho, Juan Manuel, Gloria Moraleda, Javier Bartolomé, et al.. (1994). Analysis of hepatitis B precore region in serum and liver of chronic hepatitis B virus carriers. Journal of Hepatology. 21(3). 353–360. 18 indexed citations
16.
Navas, Sonia, Jorge del Romero, Soledad García, et al.. (1993). Treatment with recombinant α‐interferon of chronic hepatitis C in anti‐HIV‐positive patients. Journal of Medical Virology. 40(2). 107–111. 70 indexed citations
17.
Porres, Juan Carlos, et al.. (1991). [Reactivation of hepatitis B virus in chronic carriers with anti-HBe].. PubMed. 189(2). 68–72. 1 indexed citations
18.
Porres, Juan Carlos, et al.. (1990). Changes in Anti-Idiotype Antibodies against Anti-HBs during Recombinant Interferon Treatment of Chronic Hepatitis B. Journal of Interferon Research. 10(4). 367–373. 2 indexed citations
19.
Carreño, V., et al.. (1988). Prevalencia de hepatitis por virus A, B y D en niños. Anales de Pediatría. 29(5). 357–362. 3 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by C Naret Breakdown of academic impact, for papers by A.L.W.F. Eddleston Breakdown of academic impact, for papers by C Martín-Vega Breakdown of academic impact, for papers by Ulrike Mihm Breakdown of academic impact, for papers by V. Carreño Breakdown of academic impact, for papers by Terryl J. Ortego Breakdown of academic impact, for papers by Nai‐Jen Hou Breakdown of academic impact, for papers by A. Bionda Breakdown of academic impact, for papers by M Duffaut Breakdown of academic impact, for papers by Blaine Hollinger
Rankless by CCL
2026